Zura Bio Limited's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows investors what the company wants to emphasize about its business to potential partners.
Expanded stock option pool helps company attract and keep talented employees and leaders.
Board changes can signal company direction or internal shifts that affect investor confidence.
Quarterly earnings show whether the company is making progress and spending money wisely.
Detailed financial data lets investors check the company's cash, spending, and progress on goals.
New CFO at $366,415 salary manages company finances; changes signal leadership continuity or shifts.
Annual report shows total revenue, losses, and assets—key facts for understanding company health.
Stocky reads Zura Bio Limited's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Zura Bio Limited's most recent tracked filing was a 8-K on 1 Jul 2026: Updated corporate presentation for conferences and meetings.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.